New Appointment Extends Freeman Technology’s Applications Team
News Apr 22, 2013
Educated to PhD level, Doug has a background in chemistry and considerable experience in supporting the use of high precision scientific instrumentation. He is based at Freeman Technology’s headquarters in the UK and will be involved in supporting users of the FT4 Powder Rheometer® right through from initial installation and training to ongoing education and applications support.
Welcoming Doug to the team, Managing Director Tim Freeman said: “FT4 users around the world know they can call on the expertise and experience both of our representatives on the ground and the team working at our UK headquarters, where we continue to invest strongly in our R&D and applications support. The FT4 Powder Rheometer is now used in a diverse range of industrial situations and we are growing our teams to ensure that we continue to develop the customer support excellence for which we are known.”
Doug Millington-Smith will be involved in installing Instruments at user sites and providing initial user training. Users will then be able to turn to him for remote advice and continued support in all areas including analysis and data interpretation if needed.
“The fact that Freeman Technology demonstrates the potential of its products through meaningful research makes it a very attractive company to work for,” said Doug. “I am delighted to now be part of such a successful team and am enjoying helping people across many different areas of powder characterization to make the most of their experience with our instruments.”
Metabolomic Profiling Identifies Taurine as New MS TherapeuticNews
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.READ MORE
Chemists Have Synthesized New Isoquinoline DerivativesNews
Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.READ MORE
Researchers Develop a Platform to Produce Brand-new AntibioticsNews
A team of scientists at the University of Bristol have generated a brand-new platform that will allow the production of desperately needed brand-new antibiotics.READ MORE